Antares Pharma, Inc. (ATRS)

Operating Cash Flow (Statement)

$29.76M

TTM · Period ending: · USD

ATRS logo

ATRS Operating Cash Flow (Statement)

Latest reported$29.76M
ATRS Cash from Operations (-$2.64M → $29.76M)
High-resolution chart · PNG

ATRS operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
36,619,000
21,320,000
-10,615,000
-17,322,000
-23,094,000
-15,194,942
-28,198,841
-26,333,301
-14,968,151
-10,472,988
-1,926,007
-6,079,370
-5,099,560
-10,324,412
-5,394,276
-6,118,050
-7,218,529
-7,167,313
-3,553,323
-5,553,766
-2,654,480
-3,732,123
-2,633,490
-5,011,881
-3,121,669
-2,642,311
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.